Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Kaiser Permanente's Dual Purpose Funding Venture

This article was originally published in Start Up

Executive Summary

Kaiser Permanente Ventures has been carving out an unusual niche for itself in the straightforward world of corporate venture funding. While return on investment is of utmost importance to most venture funds, KP's mission is broader. Under the direction of Chris Stenzel, its goal is to not only achieve economic success but to improve quality of services and offer new ways of delivering care to members and communities.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

SC090302

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel